Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine Premedication for Suspension Laryngoscopy
NCT02108171Completed
- Sponsor
- Guangzhou First People's Hospital
- Start
- Mar 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in benign neoplasm of vocal fold comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Extubation Time After Intranasal Dexmedetomidine Premedication at 1 day. Started Mar 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
benign neoplasm of vocal fold
Beyond the preview
Go deeper on NCT02108171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108171.